Published in Int J Cancer on April 23, 2015
Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions. Oncotarget (2016) 0.81
Immunohistochemical expression of heparanase isoforms and syndecan-1 proteins in colorectal adenomas. Eur J Histochem (2016) 0.78
Epigenetics and Colorectal Neoplasia: the Evidence for Physical Activity and Sedentary Behavior. Curr Colorectal Cancer Rep (2015) 0.75
Favorable lifestyle before diagnosis associated with lower risk of screen-detected advanced colorectal neoplasia. World J Gastroenterol (2016) 0.75
Epidemiology and biology of physical activity and cancer recurrence. J Mol Med (Berl) (2017) 0.75
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol (1992) 17.17
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology (2003) 14.67
Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol (2001) 10.16
Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA (2003) 10.05
Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol (1994) 9.90
Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90
Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2012) 8.51
Vital signs: current cigarette smoking among adults aged ≥18 years--United States, 2005-2010. MMWR Morb Mortal Wkly Rep (2011) 8.45
Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med (2006) 8.18
Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst (2001) 5.97
Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med (1995) 5.42
Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst (2005) 5.32
Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med (1992) 5.18
Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst (2006) 5.17
Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals. Epidemiology (1996) 4.37
Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. JAMA (2011) 4.21
Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol (2000) 3.94
Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA (2005) 3.88
Five-year colon surveillance after screening colonoscopy. Gastroenterology (2007) 3.74
Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology (2007) 3.73
A prospective study of aspirin use and the risk for colorectal adenoma. Ann Intern Med (2004) 3.46
Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann Intern Med (2003) 3.39
Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. Am J Clin Nutr (2011) 3.27
Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst (1993) 3.25
Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Gastroenterology (2004) 3.22
Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med (2004) 3.18
Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev (2007) 3.16
Television viewing and time spent sedentary in relation to cancer risk: a meta-analysis. J Natl Cancer Inst (2014) 3.15
Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer (2009) 3.13
Vital signs: colorectal cancer screening test use--United States, 2012. MMWR Morb Mortal Wkly Rep (2013) 3.12
Alcohol, low-methionine--low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst (1995) 3.10
Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol (2008) 2.56
Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst (2004) 2.54
Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening. Clin Gastroenterol Hepatol (2013) 2.30
Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention. Cancer Causes Control (2000) 2.19
Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol (2003) 2.12
Prevalence of advanced colorectal neoplasia in white and black patients undergoing screening colonoscopy in a safety-net hospital. Ann Intern Med (2013) 2.04
A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut (2014) 1.83
Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut (2007) 1.79
The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am (2002) 1.73
National Institutes of Health state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening. Ann Intern Med (2010) 1.67
Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States. Aliment Pharmacol Ther (2004) 1.65
Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses' Health Study. Am J Epidemiol (2009) 1.62
Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol (2008) 1.59
Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. Cancer Causes Control (2005) 1.55
Validation of a model of lung cancer risk prediction among smokers. J Natl Cancer Inst (2006) 1.55
Power and sample size estimation for the Wilcoxon rank sum test with application to comparisons of C statistics from alternative prediction models. Biometrics (2008) 1.49
Development of a risk score for colorectal cancer in men. Am J Med (2007) 1.39
Physical activity and risk of colon adenoma: a meta-analysis. Br J Cancer (2011) 1.20
Mathematical models of ovarian cancer incidence. Epidemiology (2005) 1.19
Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies. PLoS Med (2013) 1.11
Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis. Hum Reprod Update (2009) 1.06
Capacity for colorectal cancer screening by colonoscopy, Montana, 2008. Am J Prev Med (2009) 1.05
Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk Chinese. Am J Epidemiol (2012) 1.02
Periodontal disease, tooth loss and colorectal cancer risk: Results from the Nurses' Health Study. Int J Cancer (2016) 1.09
Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrate. Int J Cancer (2016) 0.81
Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers. Int J Cancer (2017) 0.75
Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses' Health Study and Health Professionals follow-up study. Int J Cancer (2016) 0.75